Aquestive Therapeutics Inc
NASDAQ:AQST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
US |
|
Neuronetics Inc
NASDAQ:STIM
|
US |
|
1nkemia IUCT Group SA
MAD:IKM
|
ES |
|
T
|
Toyo Asano Foundation Co Ltd
TSE:5271
|
JP |
|
C
|
Conformis Inc
F:308
|
US |
|
RFA Financial Inc
TSX:RFA
|
CA |
|
N
|
Ngan Son JSC
VN:NST
|
VN |
|
Qilian International Holding Group Ltd
NASDAQ:BGM
|
CN |
|
Bure Equity AB
STO:BURE
|
SE |
|
S
|
SVC Industries Ltd
BSE:524488
|
IN |
Shareholder Yield
Current shareholder yield for AQST is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AQST Price
Aquestive Therapeutics Inc
| Average Annual Return | 31.89% |
| Standard Deviation of Annual Returns | 89.8% |
| Max Drawdown | -90% |
| Market Capitalization | 517.5m USD |
| Shares Outstanding | 122 050 000 |
| Percentage of Shares Shorted | 16.62% |
